![]() The Centers for Disease Control and Prevention (CDC) will continue to study the vaccine for these younger children to see if any potential link appears. What we do know: COVID-19 vaccines save lives Typically within 4 days after vaccination. More often following dose 2 than dose 1, and Mostly in adolescents and young-adult males, especially those 16 years of age and older, The reports of myocarditis after COVID-19 vaccination were seen: And in the clinical trials of more than 3,000 children age 5 to 11, there were no reports of myocarditis from the vaccine. ![]() Most got better on their own or with minimal treatment and rest. The chance of having this occur is very low.Ĭlinical trials studying the vaccine in kids 12 to 17 years, a small number of adolescents and young adults experienced mild cases of myocarditis after getting the COVID-19 vaccine. In most of these people, symptoms began within a few days following receipt of the second dose of vaccine. Very rarely, myocarditis also has occurred in some people who have received the vaccine. Symptoms can include feelings ofĪbnormal heart rhythms, shortness of breath, or In more than half of cases, no cause is identified. It happens when the body's immune system reacts to an infection or some other trigger. Myocarditis is an inflammation of the heart muscle. Your child should get the COVID-19 vaccine that isĪuthorized for their age. In fact, children are more at risk of myocarditis after multisystem inflammatory syndrome, a serious illness from COVID-19 infection.Īmerican Academy of Pediatrics recommends COVID-19 vaccination forĪll kids age 6 months and older who do not have contraindications. Reporting rates were around 70 cases per million doses in males ages 12 through 15 years and 105 cases per million doses in males ages 16 through 17 years.Compared to the potential risks of COVID-19 infection in kids, myocarditis appears to be quite rare. ![]() In reports of myocarditis following mRNA-based COVID-19 vaccination from December 2020 to August 2021, the risk of myocarditis was highest following the second dose of the Pfizer-BioNTech vaccine in adolescent and young adult males.In children ages 5 through 11 years, there were 20 confirmed reports of myocarditis out of approximately 18.1 million doses given of the Pfizer-BioNTech COVID-19 vaccine between November 2021 and April 2022.New studies have shown the rare risk of myocarditis and pericarditis associated with mRNA COVID-19 vaccination ( Pfizer-BioNTech and Moderna)-mostly among males between the ages of 12 and 39 years-may be further reduced with a longer time between the first and second dose. Rare cases of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the outer lining of the heart) have been reported after children and teens ages 5 years and older got the Pfizer-BioNTech COVID-19 vaccine. When they are reported, serious reactions most frequently occur within a few days after vaccination. Serious reactions after COVID-19 vaccination in children and teens are rare. Serious Health Events after COVID-19 Vaccination Are Rare
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |